S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Genesis Fertility Joins Progyny Network Under New Brand

Patients across the New York metropolitan area can now use Progyny fertility benefits at locations operated by the newly rebranded Pinnacle Fertility New York. The integration follows the practice's recent shift into the broader Pinnacle network, aiming to widen access to IVF, fertility preservation, and comprehensive reproductive health services.

Genesis Fertility Joins Progyny Network Under New Brand
Photo: Bio & News

The transition from the legacy Genesis Fertility brand to Pinnacle Fertility New York marks a strategic shift for the clinic, which has operated in the region for nearly four decades. By accepting Progyny coverage, the practice opens its clinical services—ranging from initial consultations to complex family-building procedures—to a significantly larger pool of employer-sponsored health plan members.

"Adding Progyny is an important milestone for New York patients and allows us to serve even more individuals and families," said Beth Zoneraich, CEO of Pinnacle Fertility. The network currently operates across Brooklyn, Queens, Staten Island, Long Island, and Manhattan. According to Medical Director Dr. Katherine Melzer-Ross, the change facilitates broader patient access without compromising the personalized, physician-led approach that defined the clinic’s original practice. This move aligns with Pinnacle’s wider strategy to scale its nationwide footprint by leveraging employer-sponsored benefit programs.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!